18 September 2020>: Database Analysis
Development and Validation of a Novel Immune-Gene Pairs Prognostic Model Associated with CTNNB1 Alteration in Hepatocellular Carcinoma
Junyu Huo ABCDEF , Liqun Wu AEF* , Yunjin Zang AEDOI: 10.12659/MSM.925494
Med Sci Monit 2020; 26:e925494
Table 3 The chi-square test of the relation between risk score and clinical features in ICGC.
Clinical feature | Risk score | χ2 | P | |
---|---|---|---|---|
High risk n(%) | Low risk n(%) | |||
Gender | 0.538 | 0.463 | ||
Male | 47 (27.81%) | 122 (72.19%) | ||
Female | 20 (32.79%) | 41 (67.21%) | ||
Age | 0.382 | 0.537 | ||
>65 | 39 (27.66%) | 102 (72.34%) | ||
≤65 | 28 (31.46%) | 61 (68.54%) | ||
Stage | 30.071 | 0.001 | ||
I–II | 23 (16.20%) | 119 (83.80%) | ||
III–IV | 44 (50.00%) | 44 (50.00%) | ||
Prior malignancy | 0.562 | 0.453 | ||
Yes | 7 (23.33%) | 23 (76.67%) | ||
No | 60 (30.00%) | 140 (70.00%) |